Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors.

      European Journal of Pharmacology

      Antipsychotic Agents, administration & dosage, pharmacology, Behavior, Animal, drug effects, Clozapine, analogs & derivatives, Dopamine D2 Receptor Antagonists, Ketamine, Male, Prolactin, blood, secretion, Rats, Rats, Sprague-Dawley, Receptor, Muscarinic M1, antagonists & inhibitors, metabolism, Receptor, Serotonin, 5-HT2A, Scopolamine Hydrobromide, Sensory Gating, Serotonin 5-HT2 Receptor Antagonists, Animals

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          N-desmethylclozapine (NDMC), one of the major metabolites of clozapine, has been demonstrated to exhibit partial agonistic activity at M(1) muscarinic receptors in vitro. Behavioral effects of NDMC were examined to determine whether NDMC contributed to the antipsychotic effects of clozapine via activation of muscarinic receptors. Both NDMC (10-30 mg/kg) and its parent compound clozapine (3-10 mg/kg) antagonized the disruption of prepulse inhibition (PPI) caused by the indirect dopamine agonist methamphetamine (3 mg/kg) in rats. However, NDMC (30 mg/kg) did not increase plasma levels of prolactin in rats. The same dose ranges of NDMC antagonized the disruption of PPI caused by the N-methyl-D-aspartate receptor antagonist ketamine (5 mg/kg) in rats. Furthermore, NDMC in the same dose ranges antagonized the disruption of PPI caused by the muscarinic receptor antagonist scopolamine (0.3 mg/kg) in rats. These findings suggest that NDMC has potent antipsychotic effects in animal models to examine sensorimotor gating function, and that NDMC may act through the activation of a muscarinic receptor for the treatment of schizophrenia. Copyright © 2011 Elsevier B.V. All rights reserved.

          Related collections

          Author and article information

          Journal
          21658379
          10.1016/j.ejphar.2011.05.063

          Comments

          Comment on this article